Technical Analysis for ADCT - ADC Therapeutics SA
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.98 | -3.88% | -0.08 |
ADCT closed down 3.88 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 5% | about 16 hours ago |
| 60 Minute Opening Range Breakdown | about 18 hours ago |
| Down 3% | about 18 hours ago |
| Possible NR7 | about 18 hours ago |
| Possible Inside Day | about 18 hours ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Solid Tumors Drugs Monoclonal Antibodies Advanced Solid Tumors Antibody Drug Conjugate Lonca Synaffix
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.04 |
| 52 Week Low | 0.6883 |
| Average Volume | 382,790 |
| 200-Day Moving Average | 3.62 |
| 50-Day Moving Average | 2.97 |
| 20-Day Moving Average | 2.79 |
| 10-Day Moving Average | 2.58 |
| Average True Range | 0.23 |
| RSI (14) | 24.24 |
| ADX | 17.2 |
| +DI | 13.15 |
| -DI | 37.13 |
| Chandelier Exit (Long, 3 ATRs) | 2.62 |
| Chandelier Exit (Short, 3 ATRs) | 2.56 |
| Upper Bollinger Bands | 3.48 |
| Lower Bollinger Band | 2.10 |
| Percent B (%b) | -0.08 |
| BandWidth | 49.58 |
| MACD Line | -0.22 |
| MACD Signal Line | -0.11 |
| MACD Histogram | -0.1094 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.21 | ||||
| Resistance 3 (R3) | 2.23 | 2.17 | 2.17 | ||
| Resistance 2 (R2) | 2.17 | 2.11 | 2.16 | 2.16 | |
| Resistance 1 (R1) | 2.07 | 2.07 | 2.04 | 2.06 | 2.15 |
| Pivot Point | 2.01 | 2.01 | 2.00 | 2.00 | 2.01 |
| Support 1 (S1) | 1.92 | 1.95 | 1.89 | 1.90 | 1.81 |
| Support 2 (S2) | 1.86 | 1.92 | 1.85 | 1.80 | |
| Support 3 (S3) | 1.76 | 1.86 | 1.79 | ||
| Support 4 (S4) | 1.75 |
